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Airway inflammationAbstract Background: Asthma is the most common chronic inflammatory disease in childhood.
The relevance of NFjB which is known to be an inflammatory marker in upper airway epithelium
and its relation to lower airway inflammation has not been fully studied in childhood asthma.
Aim of study: The study aimed at evaluating the diagnostic value of nasal lavage nuclear factor
kappa B and cells as a less-invasive bench-side maneuver and inflammatory biomarkers in asthmatic
children and correlating with asthma severity.
Methods: This case-control study recruited 60 asthmatic children from Pediatric Chest Clinic,
Children’s Hospital; Ain Shams University. Thirty healthy non-asthmatic children-age and sex-
matched were included as a control group. Nasal lavage cytology, nasal lavage NFjB and forced
expiratory volume in 1 s (FEV1) % of predicted for age and sex were estimated.
Results: Nasal lavage NFjB levels were significantly higher in asthmatics than in controls with a
mean of 0.129 ± 0.113 lg/lg nuclear proteins and 0.0176 ± 0.013 lg/lg nuclear proteins, respec-
tively. Nasal lavage NFjB and eosinophil levels were significantly higher with increasing asthma
severity and with worsening levels of asthma control. Nasal lavage NFjB showed a sensitivity of
87% and a specificity of 87% in predicting asthma severity.
Conclusions: Despite that spirometry and clinical classification are the gold standards for grad-
ing of asthma, Nasal lavage NFjB and cells can be considered as a new less-invasive non-subjective
inflammatory marker for assessment of different grades of asthma severity and control.
 2016 The Egyptian Society of Chest Diseases and Tuberculosis. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).Introduction
Bronchial asthma, a clinical complication of persistent inflam-
mation of airways and subsequent airway hyper-
responsiveness, is a leading cause of morbidity and mortality
[1]. Despite that airway inflammation is a useful marker of
550 E.M. Fouda et al.disease activity, there is less information concerning airway
inflammation in young children, in whom access to the lower
airway is a major obstacle and in whom the asthma phenotype
is thought to be more heterogeneous [2].
The upper airway, especially nasal epithelium, shares sev-
eral properties with the lower airways. Moreover, it is easily
accessible and nasal lavage (NAL) is well tolerated even by
infants as young as 4 wk old. In comparison with serum
biomarkers, measurements of NAL inflammatory markers
can be assumed to reflect airway pathology more directly.
Therefore, the determination of inflammatory markers in the
nasal epithelium fluid would be attractive for both epidemio-
logical and clinical purposes [3].
Nuclear factor kappa B (NF-kappa B) is a transcription
factor that is critical for production of many inflammatory
cytokines. It is activated in airway epithelium of both human
asthmatics and mice after allergic stimulation [4]. It has been
considered a master regulator of both innate and adaptive
immune responses and it might play a cardinal role in allergic
airway diseases [5]. Therefore, understanding various facets
of regulation of NFjB and its targets may offer the potential
to advance our knowledge of immune processes in
asthma [6]. Moreover; no studies to date have identified its
level in nasal lavage in correlation with asthma severity in
children.
Aim of the work
This study aimed at evaluating diagnostic value of nasal lavage
(NAL) nuclear factor kappa B and cytology, as a less-invasive
bench-side maneuver, as inflammatory biomarkers in asth-
matic children and to correlate it with asthma severity assessed
clinically and by forced expiratory second 1 (FEV1) % of pre-
dicted for age and sex [7]; together with NAL cellularity as an
indicator of airway inflammation.
Patients and methods
Study population and design
During the period from April, 2012 to October, 2014, this
case–control study was carried out at the Pediatric Chest
Clinic, Children’s Hospital, Ain Shams University; Cairo,
Egypt. It included 60 asthmatic children and 30-age and sex-
matched- healthy children as a control group. Patients were
selected according to the global initiative for asthma ‘‘GINA”
[7]. An informed consent was obtained from parents of both
patients and controls. The Pediatric Department Board ethi-
cally approved the study. None of the patients had a respira-
tory tract infection or exacerbation of asthma during
enrollment. None of the asthmatics gave history for allergic
rhinitis or previous nasal steroid intake (to assess local nasal
epithelium as a representative for the lower airway inflamma-
tion). Neither asthmatics nor healthy children were exposed to
second-hand tobacco smoking which may increase airway
inflammation and NFjB level.
Asthmatic patients were further subdivided into allergic
and non-allergic; based on atopic history and/or previous
positive skin prick test [8]. Levels of asthma control were
systematically assessed using GINA guidelines [7] during past
three months: controlled versus partially/uncontrolled asthma.Severe exacerbations, according to ATS/ERS definition [9] and
the number of days with symptoms (GINA guidelines) were
specifically recorded.
Both patients and controls were examined, and then under-
went spirometry and venous blood samples were collected to
determine complete blood count for eosinophilia and nasal
lavage fluid sampling for cytology and measurement of NFjB
level.Spirometry
A dynamic spirometry (Jaeger, Germany) was done for mea-
surement of FEV1% of predicted; according to standards of
the European Respirator Society and the American Thoracic
Academy [10]. We used the highest values of FEV1 of three
forced expiratory maneuvers.
Nasal lavage sampling
We clearly explained the maneuver for the child and parents as
described [3]. Older children (P7 y) sat on a chair, with their
head bent backward; they were instructed to hold their breath
and to make a hiccup sound thus to close soft palate and pre-
vent fluid being swallowed. We instilled 5 ml of pre-warmed
isotonic using a needleless syringe. Then the child was asked
to hold his/her breath for 10 s and then expel the fluid into a
specimen cup. For younger children, lavages were performed
in a supine position. Pre-warmed (2 ml) isotonic saline was
instilled into each nostril and immediately aspirated into a
specimen trap by inserting a flexible suction catheter. After
washing each nostril, 1 ml of saline was aspirated through
the catheter to rinse secretions into the trap. A proteinase inhi-
bitor ‘‘phosphoramidon” was added to the specimen cup
before collection of the expelled fluid [11–13].
NAL cytology
For analysis of cellular components, samples were processed
quickly. A mucolytic agent; dithioerythritol (Sputalysin) was
added to the NAL sample. After centrifugation, total cell
count was obtained by a manual hemocytometer and differen-
tial cell counts by preparation of cytocentrifuge slides. Speci-
mens were stained using the May-Gru¨nwald-Giemsa method.
Eosinophil, macrophage, lymphocyte and neutrophil counts
are then expressed as cell count  104/ml [12–14]. Aliquots of
the supernatant were stored at 70 C for later analysis of
NFjB.
Nasal lavage fluid NFjB measurement
Nuclear protein was isolated from the thawed cell pellet in a
three step process according to the manufacturer’s instructions
(Nuclear Extract Kit; Cayman chemical company, Ann Arbor,
MI, USA). The protein concentration was determined by Coo-
massie protein assay. NFjB in nuclear protein extract was
determined by enzyme linked immunosorbent assay (Cayman
chemical company). Assay specificity was confirmed by using
the provided competitive oligonucleotides. The provided HeLa
cell extract was used to produce a standard curve. Results were
expressed as concentration of NFjB lg/lg nuclear protein.
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Statistical analysis was performed using (SPSS, Inc, Chicago,
Illinois, USA) version 15. Data were presented as mean and
standard deviation. Categorical variables were expressed as
count and percentage. Unpaired t test and Mann–Whitney
U-test were used to analyze differences between two groups.
Comparison of three groups was performed using analysis of
variance and Fisher’s protected least significant difference test
or chi-squared test. Correlations between data were analyzed
using Pearson correlation test. Receiver operating characteris-
tic ‘‘ROC’’ curve was performed to define best cut-off, sensitiv-
ity and specificity. Analyses with resultant P 6 0.05 were
determined significant.Table 1 Characteristics of asthmatic patients and healthy controls.
Characteristic data
Age in years, Mean ± SD
Sex (male/female)
Positive history for atopy**
Residence Urban
Rural
BMI kg/m2, Mean ± SD
FEV1% pred., Mean ± SD**
Blood eosinophils %, Mean ± SD**
NAL NFjB (lg/lg nuclear proteins), Mean ± SD**
NAL Cell count (cells  104/ml) Neutrophils, Mean ± SD**
Eosinophils, Mean ± SD**
Squamous epithelium, Mean
ICS, inhaled corticosteroid; FEV1, forced expiratory volume in 1 s; % pr
Nasal lavage; NFjB, nuclear factor kappa b.
** P< 0.05 (significant).
Table 2 Nasal lavage of asthmatic children in relation to severity;
Mild interm
(n= 22)
NAL cell count (cells  104/
ml)
Neutrophils, Mean
± SD**
4.8 ± 1.48
Eosinophils, Mean
± SD**
6.84 ± 3.01
NAL NFjB, Mean ± SD** (lg/lg nuclear proteins) 0.056 ± 0.0
Uncontrolle
(n= 14)
NAL cell count (cells  104/
ml)
Neutrophils, Mean
± SD**
6.1 ± 8.74
Eosinophils, Mean
± SD**
7.82 ± 3.46
NAL NFjB, Mean ± SD** (lg/lg nuclear proteins) 0.059 ± 0.0
NAL cell count (cells  104/ml) Neutrophils, Mean ± SD
Eosinophils, Mean ± SD**
NAL NFjB, Mean ± SD** (lg /lg nuclear proteins)
** P< 0.05 (significant).Results
Characteristics of asthmatic and healthy control groups are
shown in Table 1. Twenty asthmatic children had history of
atopy, however after considering a previously positive skin
prick test, the allergic asthmatics represented (42/60; 70%).
Most studied children belonged to an urban residence near
to our center (Cairo, Egypt), so residence cannot be attributed
as a predisposing factor for asthma in our study. FEV1% of
predicted for age and sex was lower with statistical significance
among asthmatics when compared to the control group and
among asthmatics with increasing asthma severity
(P< 0.05). Blood eosinophil percent was significantly higher
among asthmatics when compared to healthy controlAsthmatics (n= 60) Controls (n= 30)
8.7 ± 3.74 8.15 ± 3.19
36/24 19/11
10 (33.3%) 0.00
46 (76.7%) 27 (90%)
14 (23.3%) 3 (10%)
17.80 ± 1.52 17.03 ± 0.94
80.96 ± 12.72 97.90 ± 1.74
5.11 ± 3.81 0.70 ± 0.75
0.129 ± 0.113 0.0176 ± 0.013
6.8 ± 11.48 4.133 ± 4.32
7.86 ± 2.116 0 ± 0.40
± SD 16.0 ± 14. 81 15.0 ± 21.48
ed., percentage of the predicted value; BMI, body mass index; NAL,
atopy and control.
Asthmatics (n= 60)
ittent Mild persistent
(n= 12)
Moderate to severe
(n= 26)
5.5 ± 1.92 5.8 ± 1.74
7.01 ± 5.08 7.86 ± 4.63
36 0.087 ± 0.051 0.184 ± 0.091
d Partial-control
(n= 28)
Controlled
(n= 18)
5.3 ± 2.91 4.4 ± 1.48
6.99 ± 5.18 4.94 ± 1.01
30 0.078 ± 0.047 0.26 ± 0.117
Allergic (n= 42) Non-allergic (n= 18)
5.21 ± 1.87 4.97 ± 1.66
7.66 ± 1.24 3.789 ± 2.17
0.145 ± 0.105 0.126 ± 0.123
Figure 2 Receiver operating characteristic (ROC) curve for
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severity (P< 0.05). The nasal lavage fluid eosinophils were
higher with statistical significance among asthmatics when
compared to healthy controls (Table 1) (P< 0.05), and among
asthmatics with increasing asthma severity (Table 2)
(P< 0.05). In addition, nasal lavage fluid eosinophil count
was higher with statistical significance among allergic asthmat-
ics when compared to non-allergic asthmatics (P< 0.05)
(Table 2).
Nasal lavage fluid NFjB levels were significantly higher in
asthmatics than in controls with a mean of 0.129 ± 0.113 lg/
lg nuclear proteins and 0.0176 ± 0.013 lg/lg nuclear pro-
teins, respectively (Table1).
NAL NFjB levels were significantly higher in moderate to
severe followed by mild persistent then mild intermittent asth-
matics with a mean of 0.184 ± 0.091 lg/lg proteins and 0.087
± 0.051 lg/lg proteins and 0.056 ± 0.036 lg/lg proteins,
respectively (Table 2) (Fig. 1) .
When calculating area under ROC curve (Fig. 2), the best
cut-off value for nasal lavage fluid NFjB was 0.034 lg/lg
nuclear proteins to predict asthma with a sensitivity of 87%
and specificity 87%.
There were positive significant correlations between NAL
NFjB and blood eosinophil percent, NAL eosinophils, and
NAL neutrophils among asthmatics (Table 3). Moreover, it
showed a significant negative correlation with FEV 1% among
them while, there were no significant correlations between
NAL NFjB and age, duration of illness, body mass index
(BMI), dose and duration of inhaled steroid therapy.
Discussion
Asthma is a series of complex, overlapping individual diseases
or phenotypes, each defined by an interaction between genetic
and environmental factors. NFjB exerts a key role in perpet-
uating inflammatory reactions in asthma, and levels of NFjB
expression increase with severity [15]. There is an association
between concentration of inflammatory markers and cells in
samples from lower airways and clinical severity of asthma.
Hence, the upper airway, specifically the nasal epithelium,
shares many properties with the lower airway. Moreover, nasalFigure 1 Nasal lavage NFjB in different grades of asthma.lavage (NAL) is easily accessible and well tolerated [3]. The
current study was designed to assess the role of NAL NFjB
as an inflammatory biomarker in grading of asthma severity
and control.
In the present study, nasal lavage fluid NFjB levels were
significantly higher in all asthmatics compared to healthy con-
trols, and among asthmatics with increasing asthma severity.
In addition, it correlated negatively with indices of forced expi-
ratory volume second 1(FEV1).
Although all patients were compliant on inhaled steroid
therapy, not all of them show full control. NAL NFjB levels
were higher in uncontrolled/partially controlled asthmatics
than those fully controlled. Our study reported 70% of asth-
matics being allergic; they also had higher levels of NAL
NFjB when compared to non-allergic children.
These results are in relative concordance with many lines of
evidence that indicate enhanced NFjB pathway activation in
asthmatic tissues. Peripheral blood mononuclear cells
(PBMCs) of adult uncontrolled, severe and moderate asthmat-
ics have higher levels of NFjB p65 protein expression than
normal individuals [16]. Also in children, NFjB p65 protein
abundance is also higher in moderate asthmatic peripheral
blood mononuclear cells when compared to normal individu-
als [17]. Furthermore, when compared to non-asthmatic indi-
viduals, both nuclear extracts from sputum cells, bronchialNAL NFjB to predict bronchial asthma.
Table 3 Correlations between NLF NFjB and Other Vari-
ables of Asthmatic Group.
Variables R P Sig*
Age (years) 0.162 0.216 NS
Duration of illness (years) 0.191 0.313 NS
BMI (kg/m2) 0.051 0.699 NS
Blood eosinophils% 0.874 0.00 HS
FEV 1% of predicted 0.838 0.00 HS
NAL eosinophils (cell  104/ml) 0.635 0.00 HS
NLF neutrophils (cell  104/ml) 0.541 0.00 HS
Dose of inhaled steroid (mcg/day) 0.236 0.209 NS
Duration of inhaled steroid (months) 0.013 0.947 NS
BMI, body mass index; *S, significant; HS, highly significant; NS,
non significant.
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stable, untreated asthmatics have greater levels of NFjB p65
[19].
Furthermore, being higher among allergic asthmatics
comes in agreement with Cristen et al. [20], who demonstrate
that selective activation NF-kappa B in airway epithelium is
sufficient to induce airway hyper-responsiveness and smooth
muscle thickening, which are both critical features of allergic
airway disease.
These results are also in concordance with Abdulamir et al.
[15] who found that NFjB exerts a key role in perpetuating
inflammatory reactions in asthma, and levels of NFjB expres-
sion increase with severity.
In the present work, NAL cytology revealed higher counts
of eosinophils (denoting eosinophilic airway inflammation),
then neutrophils, and lymphocytes in asthmatic patients when
compared to the control group, as the contribution of eosino-
phils, neutrophils and lymphocytes has been well established in
the patho-physiology of asthma [21,22].
These results are in concordance with Noah et al. [13,23]
who reported high levels of NAL eosinophils in asthmatic chil-
dren when compared to non-asthmatic children. Also, they
come in relative agreement with Carroll et al. [24] who
reported increased levels of lymphocytes and eosinophils in
airway biopsy specimens in asthmatic patients. Similarly, both
Jung et al. [21] and Spahn et al. [25] reported that, sputum eosi-
nophilia predicts asthma relapse in asthmatic children.
However in another study, Fahy [26] reported that neu-
trophils accumulate in the airway in more severe forms of
chronic severe asthma, and neutrophil numbers are associated
with chronic airway narrowing. In addition, neutrophils are
prominent during acute severe asthma exacerbations, where
it is possible that they have roles in both the initiation and res-
olution of attacks.
Current results also disagree with Hart et al. [18] who
reported that sputum neutrophil numbers were similar in both
asthmatic and non asthmatic group.
Also NAL eosinophils were significantly higher in allergic
asthmatic patients when compared to the non-allergic asth-
matic group, which is in concordance with Venge [27] who
reported that eosinophils are found at increased numbers in
asthma and so in allergic as compared with non-allergic
asthma. NAL eosinophils were also higher in relation to
increased asthma severity and worsening levels of control.
These findings are in relative agreement with Bousquet
et al. [28] who reported an increase in the numbers of eosino-
phils in bronchoalveolar lavage fluid in asthmatics as com-
pared with the controls, and eosinophil counts in
bronchoalveolar lavage fluid significantly correlated with the
clinical asthma score and increase with severity.
Moreover, our study calculated the best cut-off value for
nasal lavage NFjB of 3.40 lg/lg nuclear proteins to predict
asthma severity with a sensitivity of 87% and specificity
87%. Thus NAL NFjB can be an objective biomarker for
monitoring airway inflammation. However, further studies
are required in order to better elucidate its clinical significance
and association to childhood asthma with co-morbid nasal
allergy, in addition to its responsiveness to treatment.
Furthermore, as the technology and therapeutic agents
become increasingly available, therefore, the potential of tar-
geting the NFjB pathway in asthma is a challenge for further
clinical pharmacology studies.Conclusion
Despite that spirometry and GINA guidelines are gold stan-
dards for grading of asthma, they cannot assess the degree
of airway inflammation. Nasal lavage is a safe bench-side
maneuver that can give an idea about airway inflammation
by assessing its cellularity in different grades of asthma sever-
ity. Nasal lavage fluid cytology can be done as a prognostic test
before stepping up or down treatment. NAL NFjB level can
predict asthmatics from non-asthmatics. It can be considered
as a new relatively non-invasive marker for assessment of dif-
ferent grades of asthma severity and control. It can be used for
indirect detection and monitoring of airway inflammation, dis-
ease severity, and response to steroid treatment in asthmatic
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